<?xml version="1.0" encoding="UTF-8"?>
<ref id="B177-ijerph-17-05648">
 <label>177.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Chen</surname>
    <given-names>Y.W.</given-names>
   </name>
   <name>
    <surname>Yiu</surname>
    <given-names>C.B.</given-names>
   </name>
   <name>
    <surname>Wong</surname>
    <given-names>K.Y.</given-names>
   </name>
  </person-group>
  <article-title>Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL pro) structure: Virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates</article-title>
  <source>F1000Research</source>
  <year>2020</year>
  <volume>9</volume>
  <fpage>129</fpage>
  <pub-id pub-id-type="doi">10.12688/f1000research.22457.2</pub-id>
  <pub-id pub-id-type="pmid">32194944</pub-id>
 </element-citation>
</ref>
